Tech Company Financing Transactions
InterVene Funding Round
On 10/8/2024, InterVene announced $13 million in Series A funding from RiverVest Venture Partners, Treo Ventures and private investors.
Transaction Overview
Company Name
Announced On
10/8/2024
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Series A
Investors
RiverVest Venture Partners (Lead Investor)
Treo Ventures (Lead Investor) (Brad Vale)
Proceeds Purpose
The company intends to use the funds to further enhance the final development of its Recana catheter system, initiation of clinical cases, regulatory submission, and market clearance in the United States.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
415 Grand Ave. 302
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
InterVene is an up and coming medical device start-up company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Fletcher Wilson
Chief Operating Officer
Jeffrey Elkins
VP - R & D
Michi Garrison
VP - Regulatory Affairs
Tracy Roberts
Browse more venture capital transactions:
Prev: 10/8/2024: Third Dimension venture capital transaction
Next: 10/8/2024: TensorWave venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs